SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-156432
Filing Date
2021-05-10
Accepted
2021-05-10 17:18:01
Documents
4
Period of Report
2021-05-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d467786d8k.htm 8-K 22306
2 EX-10.1 d467786dex101.htm EX-10.1 21231
3 EX-99.1 d467786dex991.htm EX-99.1 11579
4 GRAPHIC g467786dsp3.jpg GRAPHIC 2816
  Complete submission text file 0001193125-21-156432.txt   60501
Mailing Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140 617-949-4100
Codiak BioSciences, Inc. (Filer) CIK: 0001659352 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39615 | Film No.: 21908502
SIC: 2836 Biological Products, (No Diagnostic Substances)